Hematology & Oncology

Research output

Research output per year 1956 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

• 1864 Article
• 260 Review article
• 101 Comment/debate
• 72 Letter
• 122 More
  • 63 Editorial
  • 37 Chapter
  • 18 Short survey
  • 2 Book
  • 2 Conference contribution

Research output per year

Research output per year

Search results

• 2022

  A Method for Orthotopic Transplantation of Lung Cancer in Mice

  Wilson, A. N., Chen, B., Liu, X., Kurie, J. M. & Kim, J., 2022, Methods in Molecular Biology. Humana Press Inc., p. 231-242 12 p. (Methods in Molecular Biology; vol. 2374).

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Lung Neoplasms 100%
  • Transplantation 96%
  • Neoplasms 40%
  • Hedgehogs 33%
  • Heterologous Transplantation 32%
  3 Scopus citations

• Coagulation factor concentrates and pharmacologic therapies for acquired bleeding disorders

  Bavli, N. & Sarode, R., Jul 10 2022, Rossi's Principles of Transfusion Medicine. wiley, p. 443-452 10 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Blood Coagulation Factors 100%
  • Thromboplastin 97%
  • recombinant FVIIa 81%
  • Vitamin K 67%
  • Hemorrhage 56%

• Organoid Co-culture Methods to Capture Cancer Cell–Natural Killer Cell Interactions

  Chan, I. S. & Ewald, A. J., 2022, Methods in Molecular Biology. Humana Press Inc., p. 235-250 16 p. (Methods in Molecular Biology; vol. 2463).

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Organoids 100%
  • Coculture Techniques 75%
  • Cell Communication 71%
  • Natural Killer Cells 70%
  • Neoplasms 24%
  7 Scopus citations
• 2021

  Antiplatelet and anticoagulant agents

  Ibrahim, I. F. & Rice, L., Jan 5 2021, Management of Bleeding Patients. Springer International Publishing, p. 289-301 13 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Platelet Aggregation Inhibitors 100%
  • Anticoagulants 81%
  • Fibrinolytic Agents 53%
  • Vitamin K 25%
  • Thromboembolism 24%
• 2019

  Exome sequencing of drug-resistant clones for target identification

  Han, T. & Nijhawan, D., 2019, Methods in Molecular Biology. Humana Press Inc., p. 175-187 13 p. (Methods in Molecular Biology; vol. 1888).

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Exome 100%
  • Clone Cells 66%
  • Whole Exome Sequencing 49%
  • Mutation 46%
  • In Vitro Techniques 36%
  2 Scopus citations

• Total methionine restriction treatment of cancer

  Hoffman, R. M., Kokkinakis, D. M. & Frenkel, E. P., 2019, Methods in Molecular Biology. Humana Press Inc., p. 163-171 9 p. (Methods in Molecular Biology; vol. 1866).

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Methionine 100%
  • Brain Neoplasms 44%
  • Heterografts 43%
  • Growth 32%
  • Neoplasms 31%
  2 Scopus citations
• 2018

  Clinical presentation and diagnosis of small cell lung neoplasms

  Dowell, J. E., Mar 19 2018, Trachea, Lung, and Pleura. World Scientific Publishing Co., Inc, Vol. 2-3. p. 171-175 5 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

• Thrombophilia: Contemporary perspectives

  Nagalla, S. & Shen, Y. M., Jan 1 2018, Cardiovascular Thrombus: From Pathology and Clinical Presentations to Imaging, Pharmacotherapy and Interventions. Elsevier, p. 535-541 7 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Thrombophilia 100%
  • Coronary Thrombosis 87%
  • Heparin 76%
  • Coronary Vessels 68%
  • Thrombocytopenia 59%
• 2017

  Clinical features of β-thalassemia and sickle cell disease

  McGann, P. T., Nero, A. C. & Ware, R. E., Jan 1 2017, Advances in Experimental Medicine and Biology. Springer New York LLC, p. 1-26 26 p. (Advances in Experimental Medicine and Biology; vol. 1013).

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Hydroxyurea 100%
  • Thalassemia 83%
  • Sickle Cell Anemia 75%
  • Hemoglobin 63%
  • Safety 58%
  12 Scopus citations

• Substance P-saporin for the treatment of intractable pain

  Nymeyer, H., Lappi, D. A., Higgins, D., Noe, C. E. & Frankel, A. E., 2017, Milestones in Drug Therapy. Springer Basel, p. 107-130 24 p. (Milestones in Drug Therapy).

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • substance P-saporin 100%
  • Intractable Pain 64%
  • Toxin 48%
  • Biological Toxin 29%
  • Immunotoxins 27%
  1 Scopus citations
• 2016

  Challenges in the development of therapy for dry age-related macular degeneration

  Wei, C. X., Sun, A., Yu, Y., Liu, Q., Tan, Y. Q., Tachibana, I., Zeng, H. & Wei, J. Y., Oct 1 2016, Advances in Experimental Medicine and Biology. Springer New York LLC, p. 103-109 7 p. (Advances in Experimental Medicine and Biology; vol. 854).

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Xanthophyll 100%
  • Zeaxanthin 97%
  • Lutein 93%
  • Measurement Method 83%
  • Retinal 76%
  9 Scopus citations

• Chemotherapy for advanced non-small cell lung cancer

  Dietrich, M. F. & Gerber, D. E., 2016, Cancer Treatment and Research. Kluwer Academic Publishers, p. 119-149 31 p. (Cancer Treatment and Research; vol. 170).

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Non-Small Cell Lung Carcinoma 100%
  • Drug Therapy 65%
  • Maintenance Chemotherapy 33%
  • Antimetabolites 29%
  • Taxoids 29%
  16 Scopus citations

• Common coagulation disorders that may arise intraoperatively: Specifically DIC

  Nagalla, S. & Merli, G., Jun 7 2016, Anticoagulation and Hemostasis in Neurosurgery. Springer International Publishing, p. 149-152 4 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

• Intrathecal substance P-saporin for the treatment of intractable cancer pain

  Nymeyer, H., Lappi, D. A., Higgins, D., Noe, C. E. & Frankel, A. E., Jan 1 2016, Techniques of Neurolysis. Springer International Publishing, p. 197-206 10 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • substance P-saporin 100%
  • Intractable Pain 64%
  • Cancer Pain 60%
  • Saporins 29%
  • Immunotoxins 27%

• Pharmacogenomics of platelet inhibitors

  Nagalla, S., Bray, P. F. & Leal, S. M., Apr 19 2016, New Therapeutic Agents in Thrombosis and Thrombolysis: Third Edition. CRC Press, p. 49-65 17 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter
• 2015

  PI3K

  Courtney, K. D. & Cantley, L. C., Jan 1 2015, Molecular Oncology: Causes of Cancer and Targets for Treatment. Cambridge University Press, p. 218-230 13 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Phosphatidylinositol 3-Kinase 100%
  • Phosphatidylinositols 73%
  • Phosphatidylinositol 3-Kinases 48%
  • Class III Phosphatidylinositol 3-Kinases 34%
  • Protein Isoforms 31%
• 2014

  Bone-Related Issues in Oncology

  Mujtaba Rizvi, S., Collins, H. & Lipton, A., Jun 20 2014, Cancer Consult: Expertise for Clinical Practice. Wiley-Blackwell, p. 867-871 5 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Bone and Bones 100%
  • Aromatase Inhibitors 83%
  • Androgens 61%
  • Osteoporosis 29%
  • Therapeutics 27%

• Glioblastoma

  Maher, E. A. & Bachoo, R. M., Nov 13 2014, Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease: Fifth Edition. Elsevier Inc., p. 909-917 9 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Glioblastoma 100%
  • Molecular Targeted Therapy 45%
  • Temozolomide 41%
  • Alkylating Agents 39%
  • Headache 28%
  7 Scopus citations
• 2013

  Classic Immunotoxins with Plant or Microbial Toxins

  Woo, J. H. & Frankel, A., Feb 12 2013, Fusion Protein Technologies for Biopharmaceuticals: Applications and Challenges. John Wiley and Sons, p. 271-293 23 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

• MicroRNAs in Platelet Production and Activation

  Edelstein, L. C., Nagalla, S. & Bray, P. F., Nov 4 2013, MicroRNAs in Medicine. Wiley-Blackwell, p. 101-116 16 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • MicroRNA 100%
  • Platelet Activation 89%
  • Megakaryocytes 73%
  • MicroRNAs 68%
  • Thrombopoiesis 58%
  1 Scopus citations

• Stem cells and brain cancer

  Piccirillo, S. G. M., Dec 1 2013, Emerging Concepts in Neuro-Oncology. Springer-Verlag London Ltd, Vol. 9780857294586. p. 61-71 11 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Brain Neoplasms 100%
  • Neoplastic Stem Cells 85%
  • Stem Cells 78%
  • Neoplasms 34%
  • Leukemia 10%
• 2012

  Research translation and personalized medicine

  Brugarolas, J., Nov 1 2012, Renal Cell Carcinoma: Translational Biology, Personalized Medicine, and Novel Therapeutic Targets. Springer US, Vol. 9781461424000. p. 161-191 31 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Precision Medicine 100%
  • Mechanistic Target of Rapamycin Complex 1 77%
  • Kidney Neoplasms 34%
  • Neoplasms 29%
  • Molecular Biology 25%
  7 Scopus citations

• Stem-Like cells from brain tumours or vice versa?

  Piccirillo, S. G. M., Apr 1 2012, Stem Cells and Human Diseases. Springer Netherlands, Vol. 9789400728011. p. 419-431 13 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Brain Neoplasms 100%
  • Stem Cells 78%
  • Neoplastic Stem Cells 48%
  • Neoplasms 34%
  • Neural Stem Cells 17%
• 2011

  Connecting Environmental Stress to Cancer Cell Biology Through the Neuroendocrine Response

  Melhem, A. & Conzen, S., Jan 1 2011, Encyclopedia of Environmental Health, Volume 1-5. Elsevier, Vol. 1. p. V1-822-V1-827

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • cell (biology) 100%
  • environmental stress 76%
  • cancer 61%
  • tumor 39%
  • apoptosis 12%
  1 Scopus citations
• 2010

  Carbon-13 nuclear magnetic resonance for analysis of metabolic pathways

  Malloy, C. R., Maher, E., Marin-Valencia, I., Mickey, B., Deberardinis, R. J. & Dean Sherry, A., Jan 1 2010, Methodologies for Metabolomics: Experimental Strategies and Techniques. Cambridge University Press, p. 415-445 31 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Carbon-13 100%
  • Metabolic Networks and Pathways 62%
  • Magnetic Resonance Spectroscopy 52%
  • Metabolic 50%
  • NMR Spectroscopy 41%
  7 Scopus citations

• Gastrointestinal Lymphomas

  Li, H. C. & Collins, R. H., Jan 1 2010, Sleisenger and Fordtran’s Gastrointestinal and Liver Disease- 2 Volume Set: Pathophysiology, Diagnosis, Management, Expert Consult Premium Edition - Enhanced Online Features and Print. Elsevier, p. 445-460 16 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter
  1 Scopus citations
• 2009

  Dissecting the urokinase activation pathway using urokinase-activated anthrax toxin

  Liu, S., Bugge, T. H., Frankel, A. E. & Leppla, S. H., 2009, Proteases and Cancer: Methods and Protocols. Antalis, T. & Bugge, T. (eds.). p. 175-190 16 p. (Methods in Molecular Biology; vol. 539).

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  Open Access

  • anthrax toxin 100%
  • Urokinase-Type Plasminogen Activator 77%
  • Antigens 43%
  • Plasminogen Activators 35%
  • edema factor 24%
  5 Scopus citations

• Immunotoxins

  Frankel, A. E., Woo, J. H. & Neville, D. M., Dec 1 2009, Principles of Cancer Biotherapy: 5th Edition. Springer Netherlands, p. 407-449 43 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Immunotoxin 100%
  • Immunotoxins 85%
  • Ligands 45%
  • Cytotoxin 30%
  • Ligand 27%
  10 Scopus citations

• Pharmaceutical perspectives of cancer therapeutics: Current therapeutic uses of monoclonal antibodies

  Axelson, M. D. & Gerber, D. E., 2009, Pharmaceutical Perspectives of Cancer Therapeutics. Springer US, p. 321-363 43 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Therapeutic Uses 100%
  • Pharmaceutical 88%
  • Monoclonal Antibodies 88%
  • Pharmaceutical Preparations 50%
  • Magic 42%
• 2008

  Monoclonal antibody therapy of cancer

  Posada, J. G. & Frankel, A. E., Mar 26 2008, The Molecular Basis of Cancer. Elsevier, p. 671-678 8 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter
  1 Scopus citations
• 2006

  Diagnosis of deep vein thrombosis and pulmonary embolism in pregnancy

  Baker, W. F., Frenkel, E. P. & Bick, R. L., Jan 1 2006, Hematological Complications in Obstetrics, Pregnancy, and Gynecology. Cambridge University Press, p. 222-249 28 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Venous Thromboembolism 100%
  • Pulmonary Embolism 91%
  • Venous Thrombosis 88%
  • Pregnancy 55%
  • Postphlebitic Syndrome 32%

• Heparin-induced thrombocytopenia in pregnancy

  Haley, B. B., Bick, R. L. & Frenkel, E. P., Jan 1 2006, Hematological Complications in Obstetrics, Pregnancy, and Gynecology. Cambridge University Press, p. 556-569 14 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Thrombocytopenia 100%
  • Heparin 96%
  • Enoxaparin 79%
  • Pregnancy 64%
  • Low Molecular Weight Heparin 34%

• Thrombocytopenia in pregnancy

  Sarode, R. & Frenkel, E. P., Jan 1 2006, Hematological Complications in Obstetrics, Pregnancy, and Gynecology. Cambridge University Press, p. 490-505 16 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Thrombocytopenia 100%
  • Pregnancy 64%
  • Mothers 20%
  • Pregnancy Maintenance 15%
  • Fetus 8%
• 2001

  3 Positional candidate gene cloning of CLN1

  Hofmann, S. L., Das, A. K., Lu, J. Y. & Soyombo, A. A., 2001, Advances in Genetics. Vol. 45. p. 69-92 24 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Organism Cloning 100%
  • Ceroid lipofuscinosis, neuronal 1, infantile 76%
  • Genes 43%
  • Proteins 40%
  • Cysteine 20%
  13 Scopus citations
• 1985

  Immunotoxins active against human ovarian cancer cell lines

  Pirker, R., FitzGerald, D. & Frankel, A., 1985, Proceedings of the American Association for Cancer Research. Vol. VOL. 26.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter
• 1981

  Initial clinical studies of chemotherapy delivery to brain tumor patients after osmotic blood brain barrier modification

  Neuwelt, E. A., Frenkel, E. P., Diehl, J. T. & Hill, S. A., 1981, Proceedings of the American Association for Cancer Research. Vol. Vol. 22.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter
• 1980

  Extraction and quantification of daunomycin and doxorubicin in tissues

  Strauss, J. F., Kitchens, R. L., Patrizi, V. W. & Frenkel, E. P., 1980, Journal of Chromatography. 1 ed. Vol. 221. p. 139-144 6 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Daunorubicin 100%
  • Doxorubicin 81%
  • Drug 41%
  • Antineoplastic Agent 34%
  • Pharmaceutical Preparations 32%
  22 Scopus citations